COMy 2019 | Predicting MM response to cellular and immunotherapies

Paola Neri

Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, discusses how immune deregulation can be used to predict response to cellular therapies and immunotherapies, such as CAR T-cell products and monocloncal antibodies. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video